I G Schmidt-Wolf - Concepedia

Author

I G Schmidt-Wolf

Also Known As

I G H Schmidt-Wolf, I G Schmidt-Wolf, I Schmidt-Wolf, I. G. H. Schmidt-Wolf, I. G.H. Schmidt-Wolf, I. Schmidt-Wolf, I.G. Schmidt-Wolf, I.G.H Schmidt-Wolf, I.G.H. Schmidt-Wolf, INGO G.H. SCHMIDT-WOLF

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Bonn Humboldt-Universität zu Berlin University Hospital Bonn Heidelberg University Freie Universität Berlin

About

I G Schmidt-Wolf is an author at University of Bonn specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	881
2	Cell Biology	3	3	676
3	Health Sciences	2	2	117
4	Natural Sciences	1	1	75
5	Biochemistry	1	1	75

I G Schmidt-Wolf

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. I G Schmidt-Wolf, RS Negrin, Hans‐Peter Kiem, The Journal of Experimental Medicine Lymphocyte DevelopmentImmunologyImmunoeditingPathologyImmunotherapy	1991	614
A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer Hanno Riess, A. Helm, Marco Niedergethmann, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyPancreatic CancerGastrointestinal Oncology	2005	102
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas B. Mann, Alexei Gratchev, Christian Böhm, British Journal of Cancer	1999	82
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism Michael Linnebank, Hendrik Pels, N Kleczar, Neurology BiochemistryMedicineMethionine MetabolismNatural SciencesMethionine Synthesis	2005	75
Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Angela Märten, Sabine Renoth, M von Lilienfeld-Toal, PubMed	2001	70
First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM) Pieter Sonneveld, Bronno van der Holt, I G Schmidt-Wolf, Blood	2008	66
Patient‐derived dendritic cells transduced with an a‐fetoprotein‐encoding adenovirus and co‐cultured with autologous cytokine‐induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells Maria A. González‐Carmona, Angela Märten, Per Hoffmann, Liver International	2006	46
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma Michael Linnebank, Stephan Schmidt, Heike Kölsch, British Journal of Cancer	2004	42
Frequency of Hereditary Non-Polyposis Colorectal Cancer among Unselected Patients with Colorectal Cancer in Germany C. Lamberti, Elisabeth Mangold, Constanze Pagenstecher, Digestion	2006	37
MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATION Birgit Zoll, Petja Lefterova, Oliver Ebert, Cytokine InflammationAutoimmune DiseaseImmune RegulationImmunologyImmunologic Mechanism	2000	36

Page 1